文献速递胸部CT

韩国国家肺癌筛查队列中肺气肿与间质性肺异常对死亡率的预后交互作用

Prognostic Interaction between Emphysema and Interstitial Lung Abnormalities for Mortality in a Korean National Lung Cancer Screening Cohort.
PubMed 文献 · Radiol Cardiothorac Imaging · 2026-01-01

该回顾性队列纳入2019年8月至2020年12月韩国国家肺癌筛查项目124 121名受检者,从CT报告中识别肺气肿与间质性肺异常(ILAs)。肺气肿与肺癌诊断后死亡率的关联因ILA状态而异(交互作用P=0.003);两者并存时死亡风险最高(校正sHR 7.04),但ILAs是主要驱动因素。

要点

  • ILAs存在时肺气肿的预后意义减弱,ILAs是两者并存时死亡风险的主要驱动因素。
  • 肺气肿仅在无ILAs时与肺癌诊断后死亡率升高相关(校正sHR 2.32)。
  • ILAs与死亡风险升高相关,无论是否合并肺气肿(合并肺气肿时校正sHR 3.04)。

核心结论

  • ILAs削弱了肺气肿的预后意义,当两者并存时ILAs是死亡风险的主要驱动因素;两者并存时死亡风险最高(校正sHR 7.04,95%CI 5.42-9.15),但未显著高于单纯ILAs(P=0.09)。

研究设计与样本

  • 回顾性队列研究,纳入2019年8月至2020年12月韩国国家肺癌筛查项目中124 121名受检者(平均年龄61.6岁±5.3;121 876名男性),从项目记录的CT报告中识别肺气肿与ILAs,采用Fine-Gray亚分布风险模型分析肺癌诊断后死亡率与无肺癌诊断死亡率。

诊断标准与关键数值

  • 肺气肿患病率13.8%(17 082/124 121),ILAs患病率2.6%(3275/124 121),肺气肿者中ILAs占7.0%(1200/17 082)。
  • 肺气肿与肺癌诊断后死亡率的关联因ILA状态而异(交互作用P=0.003)。
  • 无ILAs时肺气肿与肺癌诊断后死亡率升高相关(校正sHR 2.32,95%CI 1.97-2.73,P<0.001)。
  • ILAs与死亡率升高相关:无肺气肿时校正sHR 5.29(95%CI 4.12-6.78),合并肺气肿时校正sHR 3.04(95%CI 2.32-3.96),均P<0.001。
  • ILAs与肺气肿并存时死亡风险最高(校正sHR 7.04,95%CI 5.42-9.15),但未显著高于单纯ILAs(P=0.09)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To investigate the prognostic interaction between emphysema and interstitial lung abnormalities (ILAs) in relation to mortality among individuals undergoing lung cancer screening (LCS). Materials and Methods This retrospective cohort study included individuals screened in the Korean National Lung Cancer Screening Program between August 2019 and December 2020. Emphysema and ILAs were identified from CT study reports found in the program records. The primary study outcomes were mortality after a lung cancer diagnosis and mortality without a lung cancer diagnosis, analyzed using Fine-Gray subdistribution hazard models. Results Among 124 121 LCS participants (mean age, 61.6 years ± 5.3; 121 876 male), 13.8% (17 082) and 2.6% (3275) had emphysema and ILAs, respectively, with ILAs present in 7.0% (1200 of 17 082) of those with emphysema. The association between emphysema and mortality after a lung cancer diagnosis differed based on ILA status (P for interaction = .003). Emphysema was associated with increased mortality only in the absence of ILAs (adjusted subdistribution hazard ratio [sHR], 2.32; 95% CI: 1.97, 2.73; P < .001). In contrast, ILAs were associated with elevated mortality regardless of emphysema status, although the association was attenuated in the presence of emphysema (adjusted sHR without emphysema, 5.29 [95% CI: 4.12, 6.78]; with emphysema, 3.04 [95% CI: 2.32, 3.96]; both P < .001). The combined presence of ILAs and emphysema conferred the highest mortality risk (adjusted sHR: 7.04; 95% CI: 5.42, 9.15), albeit not significantly higher than ILAs alone (P = .09), suggesting that ILAs drive the increased risk when the conditions coexist. Similar patterns were observed for mortality without a preceding lung cancer diagnosis. Conclusion ILAs diminished the prognostic significance of emphysema and were the primary driver of mortality risk when both conditions were present. Keywords: Lung Cancer Screening, Low-Dose CT, Interstitial Lung Abnormalities, Interstitial Lung Diseases, Emphysema Supplemental material is available for this article. © RSNA, 2026.

来源:Radiol Cardiothorac Imaging,查看原文。版权归原作者所有。

引用

  1. Kim H, Jo E, Kim J, et al. Prognostic Interaction between Emphysema and Interstitial Lung Abnormalities for Mortality in a Korean National Lung Cancer Screening Cohort. Radiol Cardiothorac Imaging. 2026. PMID: 41885620. doi:10.1148/ryct.250376

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。